Canada Life’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-43,773
| Closed | -$1.27M | – | 2592 |
|
|
2017
Q3 | $1.27M | Sell |
43,773
-3,400
| -7% | -$95.2K | ﹤0.01% | 1429 |
|
|
2017
Q2 | $1.24M | Buy |
47,173
+2,000
| +4% | +$49.2K | ﹤0.01% | 1429 |
|
|
2017
Q1 | $1.05M | Buy |
45,173
+2,128
| +5% | +$52.5K | ﹤0.01% | 1492 |
|
|
2016
Q4 | $1.08M | Hold |
43,045
| – | – | ﹤0.01% | 1452 |
|
|
2016
Q3 | $1.21M | Buy |
43,045
+2,094
| +5% | +$53.7K | ﹤0.01% | 1353 |
|
|
2016
Q2 | $1.01M | Buy |
40,951
+35,951
| +719% | +$892K | ﹤0.01% | 1404 |
|
|
2016
Q1 | $110K | Hold |
5,000
| – | – | ﹤0.01% | 1740 |
|
|
2015
Q4 | $175K | Hold |
5,000
| – | – | ﹤0.01% | 1362 |
|
|
2015
Q3 | $143K | Hold |
5,000
| – | – | ﹤0.01% | 1446 |
|
|
2015
Q2 | $166K | Hold |
5,000
| – | – | ﹤0.01% | 1480 |
|
|
2015
Q1 | $141K | Hold |
5,000
| – | – | ﹤0.01% | 1563 |
|
|
2014
Q4 | $103K | Hold |
5,000
| – | – | ﹤0.01% | 1732 |
|
|
2014
Q3 | $123K | Hold |
5,000
| – | – | ﹤0.01% | 1527 |
|
|
2014
Q2 | $142K | Buy |
+5,000
| New | +$139K | ﹤0.01% | 1341 |
|
|
2013
Q4 | – | Sell |
-400
| Closed | -$5K | – | 2300 |
|
|
2013
Q3 | $5K | Buy |
+400
| New | +$5.39K | ﹤0.01% | 1131 |
|
Canada Life's PMC Position: Q4 2017 in Review
Canada Life sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 43,773 shares — an estimated $1.27M sold.
Canada Life first reported a position in PMC in Q3 2013 and held it in 15 quarters. The position peaked at $1.27M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Canada Life reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Canada Life sold 43,773 PharMerica Corporation shares in Q4 2017, an estimated $1.27M.
- Canada Life first reported a position in PharMerica Corporation in Q3 2013 and held it in 15 quarters.
- Canada Life's PharMerica Corporation position peaked at $1.27M in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Canada Life's 13F filing for Q4 2017, filed 9 Feb 2018.